NEWTOPIA INC (NEWU.CA)
CA6532261006 - Common Stock
Taking everything into account, NEWU scores 1 out of 10 in our fundamental rating. NEWU was compared to 18 industry peers in the Health Care Providers & Services industry. NEWU has a bad profitability rating. Also its financial health evaluation is rather negative. NEWU does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NEWU had negative earnings in the past year.
NEWU had a negative operating cash flow in the past year.
In the past 5 years NEWU always reported negative net income.
In the past 5 years NEWU always reported negative operating cash flow.
1.2 Ratios
NEWU's Return On Assets of -458.15% is on the low side compared to the rest of the industry. NEWU is outperformed by 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -458.15% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-183.8%
ROA(5y)-166.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NEWU has a better Gross Margin (54.01%) than 83.33% of its industry peers.
NEWU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NEWU so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y13.03%
2. Health
2.1 Basic Checks
NEWU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NEWU has been increased compared to 1 year ago.
The number of shares outstanding for NEWU has been increased compared to 5 years ago.
NEWU has a worse debt/assets ratio than last year.
2.2 Solvency
NEWU has an Altman-Z score of -68.70. This is a bad value and indicates that NEWU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NEWU (-68.70) is worse than 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -68.7 |
ROIC/WACCN/A
WACC7.46%
2.3 Liquidity
NEWU has a Current Ratio of 0.13. This is a bad value and indicates that NEWU is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.13, NEWU is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
A Quick Ratio of 0.11 indicates that NEWU may have some problems paying its short term obligations.
NEWU's Quick ratio of 0.11 is on the low side compared to the rest of the industry. NEWU is outperformed by 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.36% over the past year.
The Revenue for NEWU has decreased by -24.25% in the past year. This is quite bad
NEWU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.06% yearly.
EPS 1Y (TTM)22.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.9%
Revenue 1Y (TTM)-24.25%
Revenue growth 3Y-5.01%
Revenue growth 5Y26.06%
Sales Q2Q%-33.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NEWU. In the last year negative earnings were reported.
Also next year NEWU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NEWU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NEWTOPIA INC
TSX-V:NEWU (9/16/2024, 7:00:00 PM)
0.01
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.73M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -458.15% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.01% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover5.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.13 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)22.36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.25%
Revenue growth 3Y-5.01%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y